An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

Completed

Conditions studied: Rosacea

In brief

The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.

Key facts

Study ID

NCT00668655

Run by

Galderma R&D

People needed

30

Starts

2008-02-01

Expected to finish

2008-03-01

Last updated by the study team

2022-07-29

Who can join

Age: 20 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with moderate Rosacea (Global Severity Score of 3),
• Subjects willing to stop their current rosacea medication for at least 2 weeks
• Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)
• Subjects must be willing to use their routine facial foundation and not change products while on study

You may not qualify if…

• Subjects who do not routinely wear facial foundation
• Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)
• Subjects who are unwilling to stop their current rosacea medications for 2 weeks

Where it is running

• Dermatology Consulting Services — High Point, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.